ZERBI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 8.920
AS - Asia 2.074
EU - Europa 1.757
SA - Sud America 448
AF - Africa 254
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 6
Totale 13.478
Nazione #
US - Stati Uniti d'America 8.837
SG - Singapore 1.217
CN - Cina 649
FI - Finlandia 422
BR - Brasile 404
IE - Irlanda 358
NG - Nigeria 235
IT - Italia 215
DE - Germania 202
FR - Francia 158
NL - Olanda 104
SE - Svezia 95
CA - Canada 67
GB - Regno Unito 67
TR - Turchia 55
BE - Belgio 33
HK - Hong Kong 31
IL - Israele 30
RU - Federazione Russa 20
IN - India 18
AR - Argentina 17
AU - Australia 17
UA - Ucraina 16
AT - Austria 10
JP - Giappone 10
MX - Messico 10
CH - Svizzera 9
CL - Cile 9
IQ - Iraq 9
IR - Iran 9
BD - Bangladesh 8
RO - Romania 8
ES - Italia 7
GR - Grecia 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
MA - Marocco 5
ZA - Sudafrica 5
AZ - Azerbaigian 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EC - Ecuador 4
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EU - Europa 3
KG - Kirghizistan 3
PK - Pakistan 3
TN - Tunisia 3
UZ - Uzbekistan 3
VN - Vietnam 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
CO - Colombia 2
EE - Estonia 2
EG - Egitto 2
GH - Ghana 2
KH - Cambogia 2
LV - Lettonia 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
PL - Polonia 2
PY - Paraguay 2
RS - Serbia 2
TW - Taiwan 2
UY - Uruguay 2
CR - Costa Rica 1
CY - Cipro 1
GA - Gabon 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MN - Mongolia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
Totale 13.478
Città #
Wilmington 1.612
Chandler 1.510
The Dalles 671
Shanghai 610
San Mateo 582
Singapore 493
Ann Arbor 482
Helsinki 417
Dublin 357
Leawood 308
Boardman 288
Lawrence 275
Princeton 275
Benin City 235
New York 186
Ashburn 185
Woodbridge 155
Paris 153
Fairfield 132
Amsterdam 95
Milan 86
Toronto 64
Seattle 62
London 52
San Diego 50
Kocaeli 39
Norwalk 36
Brussels 32
São Paulo 31
Santa Clara 28
Hong Kong 26
Abbiategrasso 24
Los Angeles 24
Falkenstein 19
Monmouth Junction 19
Redmond 14
Redwood City 14
Rio de Janeiro 14
Brasília 13
Fort Worth 13
Milwaukee 13
Springfield 13
Phoenix 12
Washington 12
Pune 10
Council Bluffs 9
Des Moines 9
Munich 9
Naples 9
Prineville 9
Belo Horizonte 8
Malatya 8
Bologna 7
Cambridge 7
Newark 7
São José dos Campos 7
Berlin 6
Campinas 6
Curitiba 6
Hanover 6
Nuremberg 6
Andover 5
Baghdad 5
Buenos Aires 5
Caxias do Sul 5
Collecorvino 5
Dhaka 5
Falls Church 5
Fortaleza 5
Reston 5
Sacramento 5
Salvador 5
Sydney 5
Athens 4
Baku 4
Belford Roxo 4
Carapicuíba 4
Guarulhos 4
Manaus 4
Moscow 4
Tokyo 4
Vitória da Conquista 4
Americana 3
Bishkek 3
Bragança Paulista 3
Brescia 3
Buffalo 3
Cabo Frio 3
Campo Grande 3
Cerquilho 3
Chicago 3
Crema 3
Cuiabá 3
Frankfurt am Main 3
Guangzhou 3
Hangzhou 3
Hanoi 3
Jerusalem 3
Lausanne 3
Maceió 3
Totale 10.010
Nome #
Serum CA 19-9 in the postsurgical follow-up of patients with pancreatic cancer 86
A Rare Case of Cushing Syndrome Caused by an Ectopic ACTH-Secreting Pancreatic Neuroendocrine Tumor in a Patient with Von Hipple-Lindau Disease 83
A Bone in the Pancreas 78
Pancreatic surgery outcomes: multicentre prospective snapshot study in 67 countries 70
An uncommon cause of massive intraperitoneal bleeding: leiomyoblastoma of the stomach. 69
Commentary to paper "Primary versus secondary delayed gastric emptying (DGE) grades B and C of the International Study Group of Pancreatic Surgery after pancreatoduodenectomy: a retrospective analysis on a group of 132 patients". 68
Can SBRT improve the prognosis of unresectable pancreatic cancer? Clinical results on 106 patients 68
Dissection of transcriptional and cis-regulatory control of differentiation in human pancreatic cancer 66
Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis. 66
The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma 66
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 65
BEYOND PALLIATION: USING EUS-GUIDED CHOLEDOCHODUODENOSTOMY WITH A LUMEN-APPOSING METAL STENT AS A BRIDGE TO SURGERY 65
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 65
"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases 64
Assessment of Perioperative Body Composition at Bioimpedance Vector Analysis (BIVA) Predicts Morbidity Following Pancreatic Resection for Cancer 64
Long-term outcomes after pancreatoduodenectomy for ampullary cancer: The influence of the histological subtypes and comparison with the other periampullary neoplasms 64
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 63
[Advances and perspectives in acute pancreatitis]. FT Novita e prospettive nella pancreatite acuta. 63
Characterisation of the immune-related transcriptome in resected biliary tract cancers 63
Diagnostic assessment and outcome of acute pancreatitis in Italy: Results of a prospective multicentre study - ProInf-AISP: Progetto informatizzato pancreatite acuta, Associazione Italiana Studio Pancreas, phase II 62
A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile 62
CA 19.9, CA 242 and CEA in the diagnosis and follow-up of pancreatic cancer 61
Prognostic value of the immune-related transcriptome in biliary tract cancers 61
A cost-benefit analysis of surgical approach to pancreatic cancer 61
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 61
Efficacy of an absorbable fibrin sealant patch (TachoSil) after distal pancreatectomy: a multicenter, randomized, controoled trial 60
The evolution of post-operative pancreatic fistula (POPF) classification: A single-center experience 60
Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy 60
The borderline resectable/locally advanced pancreatic ductal adenocarcinoma: What should be the surgeon's choice? 60
Enhanced Recovery After Pancreatic Surgery Does One Size Really Fit All? A Clinical Score to Predict the Failure of an Enhanced Recovery Protocol After Pancreaticoduodenectomy 60
A prospective multicentre survey on the treatment of acute pancreatitis in Italy 59
Consequences of Increases in Antibiotic Resistance Pattern on Outcome of Pancreatic Resection for Cancer 59
Morphohistological Features of Pancreatic Stump Are the Main Determinant of Pancreatic Fistula after Pancreatoduodenectomy 58
Value of abdominal sonography and MR imaging at 0.5 T in preoperative detection of pancreatic insulinoma: A comparison with dynamic CT and angiography 58
Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma 58
Application of minimally invasive pancreatic surgery: an Italian survey 58
AN ONCOCYTIC CARCINOMA OF THE PANCREAS WITH PULMONARY AND SUBCUTANEOUS METASTASES 57
Pancreatic enzyme replacement therapy in post-pancreatectomy patients. 57
Management and Outcomes of Pancreatic Resections Performed in High-Volume Referral and Low-Volume Community Hospitals Lead by Surgeons Who Shared the Same Mentor: The Importance of Training 57
Diagnosis and treatment of acute pancreatitis: The position statement of the Italian Association for the study of the pancreas 57
Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers 57
Ampullary neuroendocrine neoplasms: surgical experience of a rare and challenging entity 57
INTRAOPERATIVE RADIATION-THERAPY ADJUVANT TO RESECTION IN THE TREATMENT OF PANCREATIC-CANCER 57
A Partnership Model Between High- and Low-Volume Hospitals to Improve Results in Hepatobiliary Pancreatic Surgery 57
Pancreatoduodenectomy with occlusion of the residual stump by Neoprene injection. 56
Effect of Surgeon Volume on Outcome Following Pancreaticoduodenectomy in a High-Volume Hospital 56
Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy 56
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study 55
Final results of a prospective trial of a PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen followed by radiotherapy after curative surgery for pancreatic adenocarcinoma 55
A multicenter survey on distal pancreatectomy in Italy: results of minimally invasive technique and variability of perioperative pathways. 55
RELIABILITY OF PANCREATIC-CANCER STAGING CLASSIFICATIONS 55
A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: Cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel 55
Antitumorigenic and antiinsulinogenic effects of calcitriol on insulinoma cells and solid beta-cell tumors 55
Pancreatic serous cystoadenoma (CSA) showing increased tracer uptake at 68-GaDOTA-peptide Positron Emission Tomography (68Ga-DOTA-peptide PET-CT): a case report 55
Pylorus-preserving pancreaticoduodenectomy versus conventional whipple operation 54
DIABETES AND THE RISK OF PANCREATIC-CANCER 54
Parenchyma-sparing surgery for pancreatic endocrine tumors. 54
Adjuvant therapy is associated with improved overall survival in patients with pancreatobiliary or mixed subtype ampullary cancer after pancreatoduodenectomy - A multicenter cohort study 54
Different reconstruction techniques after pancreatoduodenectomy do not affect clinical and patient reported outcomes. 53
Beyond Palliation: Using EUS-Guided Choledochoduodenostomy with a Lumen-Apposing Metal Stent as a Bridge to Surgery. A Case Series 53
Pylorus-preserving pancreatoduodenectomy 53
SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. 53
Diagnosis of malignant change in duodenal villous adenoma. 52
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: A dose-finding study 52
Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. 52
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study. 52
Role of C-Reactive Protein Assessment as Early Predictor of Surgical Site Infections Development after Pancreaticoduodenectomy 51
Fat-absorptiom and gastroenteric pH profile in postsurgical pancreatic insufficiency: Role of the association of H2-receptor antagonists with pancreatic enzymes 51
Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort 51
Ultrasonic dissection versus conventional dissection techniques in pancreatic surgery: a randomized multicentre study 51
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 51
Preparazione del paziente e vie d'accesso 51
La chirurgia pancreatica oggi 51
Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS) 51
Pancreatic metastases: An increasing clinical entity. 50
[Personal experience in surgical resection of pancreatic carcinoma]. FT Esperienza personale nella chirurgia resettiva del carcinoma pancreatico. 50
Diagnosi e terapia degli insulinomi: esperienza in 28 casi 50
Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4 50
The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: Regulation of expression and potential mechanisms of antimalignant activity 50
A Snapshot of Elective Oncological Surgery in Italy During COVID-19 Emergency: Pearls, Pitfalls, and Perspectives 50
A novel insight into the anticancer mechanism of metformin in pancreatic neuroendocrine tumor cells 50
Arterial vs pancreatic phase: which is the best choice in the evaluation of pancreatic endocrine tumourswith multidetector computed tomography (MDCT)? 50
Role of preoperative biliary stents, bile contamination and antibiotic prophylaxis in surgical site infections after pancreaticoduodenectomy 49
Evaluation of UICC TNM classification for pancreatic cancer - A study of 228 patients 49
Intraoperative and postoperative radiotherapy in pancreatic cancer 49
Intrapancreatic accessory spleen mimicking a neuroendocrine tumor: magnetic resonance findings and possible diagnostic role of different nuclear medicine tests 49
Combination chemotherapy followed by chemoradiation for stage III pancreatic adenocarcinoma (PA) 49
Le ernie diaframmatiche complicate 49
European evidence-based guidelines on pancreatic cystic neoplasms 49
Complications of pancreatic surgery and the role of perioperative nutrition 49
Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma 49
BEHAVIOR OF TUMOR-MARKERS CA19.9, CA195, CAM43, CA242, AND TPS IN THE DIAGNOSIS AND FOLLOW-UP OF PANCREATIC-CANCER 49
Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours 49
Immune infiltrating cells in duodenal cancers 49
A POSTGRADUATE TEACHING COURSE IN LAPAROSCOPIC SURGERY 49
Eus-Elastography With Strain Ratio in the Diagnosis of Solid Pancreatic Lesions: A Single Center Prospective Cohort Study 48
Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasms 48
ANDROGENS USEFUL FOR DIAGNOSING PANCREATIC-CANCER 48
PANCREATIC MUCINOUS CYSTIC ADENOCARCINOMA METASTASIS TO THE RECTUM 48
The Number of Metastatic Lymph Nodes is a Useful Predictive Factor for Recurrence after Surgery for Nonmetastatic Nonfunctional Neuroendocrine Neoplasm of the Pancreas 48
Totale 5.644
Categoria #
all - tutte 120.723
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.723


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 0 0 0 0 0 0 0 0 14
2020/20212.928 16 41 10 14 7 933 473 220 557 370 7 280
2021/20221.376 75 14 52 334 15 12 45 217 134 112 280 86
2022/20234.071 613 164 383 442 388 346 7 311 753 357 269 38
2023/20242.179 169 210 464 90 37 211 111 197 53 33 185 419
2024/20253.143 71 191 132 38 39 415 211 344 554 903 245 0
Totale 13.711